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Cellular Responses to Oxidative Stress:
The [AhJ Gene Battery As a Paradigm
by Daniel W. Nebert,* Daniel D. Petersen,* and Albert J.
Fornace, Jr.t
A major source ofoxidative stress in animals is plant stress metabolites, also termed phytoalexins. The
aromatic hydrocarbon-responsive [Ah] gene battery is considered here as a model system in which we can
study metabolically coordinated enzymes that respond to phytoalexin-induced oxidative stress. In the
mouse, the [Ah] battery comprises at least six genes: two Phase I genes, CYPIAI and CYPIA2; and four
Phase II genes, Nmo-1, Aldh-i, Ugt-1, and Gt-l. All six genes appear to be regulated positively by inducers
such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other ligands of the Ah receptor. In the absence
of foreign inducer, the control of Nmo-l gene expression is independent of the control of CYPIAI and
CYPIA2 gene expression. The radiation deletion homozygote c 4Cot/C14Co5mouse is lacking about 1.1
centiMorgans of chromosome 7. Although having no detectable CYPIAI or CYPIA2 activation, the un-
treated C14CI/C14Cos mouse exhibits markedly elevated transcripts of the Nmo-i gene and three growth
arrest- andDNAdamage-inducible (gadd) genes. Thesedatasuggestthatthemissingregiononchromosome
7 in the C14CoS/C14CoS mouse contains a gene(s), which we propose to call Nmo-In, encoding a trans-acting
factor(s) that is a negative effector of the Nmo-l and gadd genes. The three other [Ah] battery Phase II
genes behave similarly to Nmo-1 in the C14CoS/C14CoS mouse. This coordinated response to oxidative stress
and DNA damage, by way of the release of a mammalian battery of genes from negative control, bears
an interesting resemblance to the SOS response in bacteria.
Introduction
From the beginning of life on earth, toxicity caused
by atmospheric oxygen has been a major challenge to
living organisms. It is well documented that in bacteria
several global regulatory mechanisms exist for the co-
ordinated expression of enzymes and proteins needed
for cellular protection against damaging agents such as
those producing oxidative stress (1-4).
The purpose ofthis review is to pull together a num-
ber ofseemingly unrelated observations concerning cel-
lular responses to environmental adversity. First, we
define oxidative stress. Next, we discuss phytoalexins,
plant stress metabolites that are a major source of ox-
ygenated metabolites in the diet of animals. Next, we
introduce the [Ah] battery, a group ofat least six genes
encoding metabolically coordinated enzymes that re-
spond to phytoalexin-induced oxidative cytotoxicity; in
addition, the Ah receptor appears to play a role in pro-
grammed cell death, or apoptosis. Finally, we suggest
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a possible link by which several genes in the [Ah] bat-
tery and several other DNA damage-inducible genes
are regulated in coordination.
Oxidative Stress Defined
Oxidative stress is produced by dioxygen and its var-
iousreactivemetabolicintermediates. Themajorcauses
of oxidative stress include ionizing irradiation, normal
metabolism at 37°C, inflammation, metabolic reactions
involving outer-shell electrons oftransition metals, and
foreign chemicals that enter the organism. A major
source ofoxidizing agents in the diet ofanimals is plant
stress metabolites, also called phytoalexins.
Phytoalexins
Phytoalexins have been defined as "low-molecular-
weight antimicrobial compounds that are both synthe-
sized by, and accumulate in, plant cells exposed to mi-
croorganisms" (5). Presumably such stress metabolites
are also important in protecting plants against insect
and other animal predators.
The response by plants to pathogen attack is illus-
trated in Figure 1. Microbial elicitors ofhost-resistance
responses include peptides and enzymes, fatty acids,
polysaccharides, and glycoproteins. Elicitors (inducers)
appear to be both exogenous and endogenous (6). TheNEBERT, PETERSEN, AND FORNACE
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FIGURE 1. Sequence ofevents by which a plant responds to a path-
ogen's signal and develops resistance to that pathogen. Although
mostly studied for microorganisms, the elicitor signal might arise
from higher organisms, e.g., insects.
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mechanism oftransduction ofthese signals (i.e., recep-
tors on the plant cell wall surface, intracellular second
messengers, or other response couplers) is poorly
understood. Ethylene biosynthetic metabolites and in-
tracellularCa2" may be involved in signaltransduction.
Theultimate response tothe elicitoristhe accumulation
of phytoalexins. Intracellular phytoalexins can be ef-
fective in killing the pathogens inside the plant cell.
However, if the pathogen remains extracellular, as in
the case of numerous bacterial and fungal infections,
the death of some plant cells is required for the release
ofphytoalexins to kill the attacking pathogen.
Phytoalexins include phenylpropanoid-, terpenoid-
and ethylene-derived chemicals, in addition to hydrox-
yproline-rich glycoproteins and proteinase inhibitors
(6). Thisreviewwillbelimited totheformeroxygenated
metabolites. Chemical structures ofrepresentative phy-
toalexins are shown in Figure 2. From the chemical
structures, it is clear that Phase I (P-450 and flavin-
containingmonooxygenases) enzymes in plants are nec-
essary for the biosynthesis and degradation of most, if
not all, ofthese phytoalexins. It should be emphasized
that many, perhaps most, of these phytoalexins are
toxic-notonly to the invadingpathogen but toanimals
ingesting the plants for food. Such toxicity might be
manifested by the parent compound directly, or by a
reactive metabolite formed inthe invading.pathogen (or
in the animal that has eaten the plant). Although very
few phytoalexins have been tested in animal cancer
bioassays, about halfofthose examined (20 of42) were
found to be carcinogenic (7).
There are tens ofthousands ofdifferent phytoalexins,
and they are extremely abundant. Although only a few
dozen stress metabolites might be present in each plant
species, they usually account for 5 to 10% ofthe plant's
dry weight (7). When plants are damaged or stressed
(e.g., by being bruised, cut, peeled, marinated in salt
or spices, heated or chilled) these phytoalexin levels
may increase many-fold in several hours (6). Ingestion
(mastication, swallowing, and gastrointestinal absorp-
tion) ofplants causes these chemicals tobereleased into
the animal.
Arecently developed strain ofcelery is aninteresting
example of the interplay between phytoalexin-induced
resistance to microorganisms and human disease (8).
The usual concentration ofthe carcinogenic phytoalexin
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FIGURE 2. Chemical structures of 12 representative phytoalexins.
8-methoxypsoralen (and related psoralens) in celery is
900 ppb and is capable of producing dermatitis among
celeryhandlers. A newvarietyofinsect-resistant celery
caused a greaterincidence ofdermatitis among produce
and grocery workers and was found to have a 10-fold
higher concentration of psoralens (9,000 ppb). As de-
scribed recently by Ames and co-workers (7), it has
become evident that the number and concentrations of
"nature's own pesticides" (i.e., phytoalexins) may be a
far greater risk to human health than man-made pes-
ticides.
Cellular Responses to Quinones
Quinones are amongthe most electrophilic and there-
fore most reactive and toxic of the phytoalexins. The
degree of quinone cytotoxicity varies greatly, depend-
Psoralen
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FIGURE 3. Diagram of the major pathways by which the cell re-
sponds to quinones. As described in the text, Nmo-1 is the most
important enzyme metabolizing quinones to hydroquinones by a
two-electron reduction pathway. Superoxide dismutase (SOD)
transforms 02 to hydrogen peroxide, which is then converted by
catalase and glutathione (GSH) peroxidase to water and oxidized
glutathione (GSSG), respectively. HQ, hydroquinone. Modified
and redrawn from Orrenius (9).
ing upon whether the quinones are metabolized by one-
electron ortwo-electron reduction pathways (Fig. 3). A
one-electron reduction leads to the formation of semi-
quinone radicals, which can regenerate the quinone and
form the superoxide anion radical 02 from dioxygen.
The reaction can cycle repeatedly between the semi-
quinone radical and the starting quinone (Fig. 3); as
redox cycling continues, this leads to cytotoxicity by
way of dismutation of °2, the formation of other reac-
tive oxygen species and free radicals, depletion of re-
duced glutathione, and decreases in the endogenous
NADPH pool. This recycling pathway can be circum-
vented by the two-electron reduction of quinones to
hydroquinonesbyNAD(P)H:menadione oxidoreductase
(NMO1) (also called DT-diaphorase and quinone reduc-
tase). These hydroquinones are usually less reactive,
more easily conjugated with glutathione and glucuro-
nide, and more easily excreted from the cell than are
semiquinone radicals (9). Hence, elevated levels of the
NMO1 enzyme would appear to protect the cell from
quinone toxicity.
The elegant pioneering studies of Orrenius and co-
workers have shown that, among the several one-elec-
tronreductionpathways, some quinones are more likely
to undergo redox cycling, whereas others are primarily
alkylating agents (10). For example (Fig. 4), o-benzo-
quinone is an extremely potent electrophile and, as
such, is involved in both alkylation and redox cycling.
In contrast, 2,3-dimethoxy-1,4-naphthoquinone under-
goes redox cycling but not alkylation. Depletion of the
endogenous NADPH pool during redox cycling leads to
enhanced levels of NADP+, which enters the mito-
chondrion and causes intramitochondrial Ca2+ to be-
come cytosolic (Fig. 5). Inhibition of the Ca2+-ATPase
during quinone alkylation inhibits the release of Ca2+
from the cell, contributing further to elevated intra-
cellular Ca2+ concentrations (12). Subsequently, other
events include intracellular alkalinization, marked in-
Hydroquinone FIGURE 4. Chemical structures ofrepresentative quinones that act
primarily by redox cycling and alkylation, respectively.
Extracellular
Ca++
FIGURE 5. Schematic illustration ofhow quinones cause toxicity by
both redox cycling and alkylation. GSQ, glutathione conjugate of
quinone; GSSG, oxidized glutathione; GSSR, glutathione cova-
lently bound to cellular macromolecules; Pi, inorganic phosphate.
Modified and redrawn from Orrenius et al. (11).
creases in phospholipase A2 activity, activation of pro-
teases, and toxic alterations in the cytoskeleton (11).
Apoptosis
Cytotoxicity is often associated with generalized
chromatin condensation, DNA fragmentation, elevated
cytosolic Ca2+ levels, intracellular alkalinization, sur-
face membrane blebbing, and activation of an endoge-
nous nuclear Ca2+-dependent endonuclease (11). Inter-
estingly, these same observations are also seen during
a sequence of events described as programmed cell
death or apoptosis (11,13-15). Apoptosis is known to
occur during embryonic development, normal tissue
turnover and hormone-dependent atrophy (Fig. 6). The
changes in chromatin, as well as the DNA damage,
probably reflect the activation of at least one endoge-
nous Ca2+-dependent endonuclease (15).
The Ah Receptor and Apoptosis
There are exogenous, as well as endogenous, stimuli
that appear to cause apoptosis. One of many such ex-
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FIGURE 6. Sequence ofevents by which an animal responds to cer-
tain endogenous or exogenous signals that lead to programmed
cell death (apoptosis) and nonspecific celldeath. Plantphytoalexins
are among the elicitors.
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FIGURE 7. Hypothetical scheme by which both TCDD and gluco-
corticosteroids can cause apoptosis in immature thymocytes. The
data are taken from McConkey et al. (18).
ternal signals is 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). The aromatic hydrocarbon-response (Ah) re-
ceptor (16) binds to TCDD and is believed to be a mem-
ber ofthe steroid/retinoid/thyroid hormone superfamily
(17). As shown in arecent fascinatingstudy (18), TCDD
andglucocorticoid hormones, bothactingbywayoftheir
respective receptors, are capable of causing apoptosis
intheimmaturethymocyte (Fig. 7). Thissuicideprocess
can be blocked by cycloheximide and by the Ca2+ ion-
ophore A23187, indicating that apoptosis is associated
with new protein synthesis and elevated intracellular
calcium levels (18). What do TCDD and glucocorticoid
hormones have in common? It is intriguing that both
are known to be potent tumor promoters (19), both ac-
tivate specific P-450 genes (16), and both cause immu-
nosuppression (20).
Role of Cytotoxicity in Tumor
Promotion
HowmightTCDD be involvedin apoptosis and tumor
promotion? As we describe below, TCDD induces en-
zymesthatgeneratemutagenic andtoxicintermediates.
These reactive oxygenated intermediates play an im-
portant role in tumor initiation as well as cytotoxicity,
which is a necessary component of tumor promotion.
DNA damage is known to lead to adduct formation
and mutation fixation, which are early critical events in
the initiation of cancer. Although DNA adduct forma-
tion is often a prerequisite, during the progression of
malignancy the process oftumor promotion is probably
at least as important as the initial mutagenic event.
Because tumor promotion has been experimentally dif-
ficult to study in most tissues, this cellular process has
only recently begun to be understood (21).
The process oftumorpromotion represents the clonal
expansion ofcellsthathave alreadyundergone aninitial
mutagenic change (21). Included in this process is the
killing ofneighboring cells sothat only afew cells might
survive and multiply. Cytotoxicity is therefore ofmajor
importance and an essential component during tumor
promotion. Interestingly, the process of tumor pro-
motion (usually caused by exogenous stimuli) shares
several characteristics with the process of apoptosis
(caused by endogenous signals): elevated cytosolic Ca2+
levels, activation ofthe Ca2+-dependent endonuclease,
and intracellular alkalinization.
Tumorpromoters suchasserumgrowthfactors, bom-
besin, plant lectins, and 12-O-tetradecanoylphorbol-13-
acetate cause protein kinase C-dependent intracellular
alkalinization (22,23), whereas Ha-ras expression does
so by an as yet unknown protein kinase C-independent
mechanism (24). Stimulation ofthe Na+/H+ antiporter
(Na+ is pumped in; H+ out), and the resulting cytosolic
alkalinization, has been observed in response to nu-
merous growth factors and mitogenic agents and is
viewed as either essential for or at least permissive of
most if not all types of epithelial cellular proliferation
(22-24). In almost every experimental system, amilor-
ide and its derivatives can inhibit intracellular alkalin-
ization and this proliferative process (23). Very re-
cently, the amiloride-sensitive Na+/H+ antiporter
proteinfromrabbitkidneyhas been purified (25). Itwill
be interesting to clone and characterize the gene en-
coding this Na+/H+ transport protein.
The [Ah] Gene Battery
What mightphytoalexin-induced oxidative stress and
apoptosis have in common? Some insight might be
gained through the use of an experimental system in
which both processes are involved. Accordingly, the
TCDD-inducible [Ah] gene battery is introduced here
as a model system for understanding a particular set of
metabolically coordinated enzymes that respond to ox-
idative stress. In addition, the Ah receptor plays some
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role in apoptosis, and phytoalexins are believed to be
among the ligands that bind to the Ah receptor.
During the past two decades, a group of six genes
has been defined as the [Ah] gene battery (16,26). In-
ducers such asTCDD, benzo[a]pyrene, 3-methylcholan-
threne, and P-naphthoflavone (Fig. 8) areknowntobind
to the Ah receptor with an apparent Kdi88 in the na-
nomolar to picomolar range. The endogenous ligand, if
one indeed exists, is not known. There are similarities
between the chemical structures ofthese ligands (Fig.
8), however, and those of several representative phy-
toalexins (Fig. 2). Hence, it is tempting to speculate
that during evolution, the Ah receptor evolved in ani-
mals as part of a transducer pathway for detecting sig-
nificant concentrations of toxic plant flavones and pro-
viding a beneficial response, i.e., the induction of
enzymesspecifically needed fordetoxifyingflavonesand
compounds of chemically related structure.
The inducer-receptor complex undergoes a temper-
ature-dependent modification beforegainingchromatin-
binding capacity. The result is an Ahreceptor-mediated
positive transcriptional activation of each of the genes
inthe [Ah] battery (16,26-29). Forsomeofthesegenes,
a component ofposttranscriptional regulation may also
be present, such as has been characterized most com-
pletely for the mouse CYP1A2 gene (26).
The TCDD-dependent Ah receptor-dependent induc-
tion in the mouse involves two Phase I genes, cyto-
chrome P1-450 (CYPlAl) and cytochrome P3-450
(CYP1A2), and four Phase II genes, NAD(P)H:mena-
dione oxidoreductase (Nmo-1), aldehyde dehydrogen-
ase (Aldh-1), UDP-glucuronosyltransferase (Ugt-1),
and glutathione transferase (Gt-1) (Fig. 9). Examples
ofthe catalytic activities ofeach ofthese six genes are
given in Figure 10. In addition to metabolizing these
i 3
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Benzo[a]pyrene
(3-Naphthoflavone
2,3,7,8-TCDD
FIGURE 8. Chemical structures of four representative ligands for
the Ah receptor (16).
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FIGURE 9. The six genes that have been defined as members ofthe
[Ah] battery (16).
substrates, each ofthese enzymes is noted for its broad
range of overlapping substrate specificities. Conse-
quently, experimental measurements of enzyme activ-
ity can lead to erroneous conclusions because the activ-
ity being determined usually reflects two or more
related genes (16,27,30). For example, the
benzo[a]pyrene hydroxylase activity represents a con-
stitutive P-450 in the IIC subfamily, in addition to the
TCDD-inducible enzyme encoded by CYPlAl in the P-
4501 subfamily (16). The importance of studying the
regulation of these genes with a specific cDNA probe
cannot be overemphasized.
It should be pointed out that the Gt-1 genes believed
to be a member of the [Ah] battery have not yet been
identified with certainty. The glutathione transferase
Yp and Ya genes are candidates for the [Ah] battery.
As will be discussed below, the [Ah] battery Phase II
enzyme activities are elevated in rat liverpreneoplastic
nodules andinducedinnormalliverbyTCDD, 3-methyl-
cholanthrene, and ,-naphthoflavone. Although the glu-
tathione transferase Yp subunit mRNA appears to be
most markedly increased in preneoplastic nodules and
hepatomas, the regulation of the glutathione transfer-
ase YamRNAinpreneoplastic nodules appearstodiffer
from one nodule to the next, whereas the Yb mRNAs
are induced by 3-methylcholanthrene (27). On the other
hand, a ,B-naphthoflavone-responsive positive regula-
tory element has been characterized in the 5' flanking
sequences ofthe Ya subunit gene (27,28).
Phase I and Phase 11 Drug-
Metabolizing Enzymes
Enzymes that metabolize drugs, phytoalexins, car-
cinogens, and other plant metabolites and environmen-
tal pollutants have classically been divided into two
broad categories. Phase I enzymes are almost exclu-
sively cytochromes P-450, which function by the inser-
tion ofone atom ofatmospheric oxygen into arelatively
inertsubstrate. Phase II enzymesactontheoxygenated
intermediates, usually by conjugating them with var-
iousendogenousmoieties(glucuronide, glutathione, sul-
fate)toproduce extremelyhydrophilicproductsthatare
easily excreted from the cell. Cytochromes P-450 are
enzymes involved in the oxidative metabolism (biosyn-
thesis as well as degradation) of steroids, fatty acids,
prostaglandins, leukotrienes, biogenic amines, phero-
mones, and plant metabolites. These monooxygenases
also metabolize countless drugs, chemical carcinogens
and mutagens, and other environmental contaminants.
The reactive intermediates formed by P-450 enzymes
can be carcinogenic, mutagenic, and/or toxic. The co-
ordinated regulation ofPhase I and Phase II genes and
the architectural arrangement of Phase I and Phase II
enzymes in each cell are, therefore, critical factors en-
suring metabolic clearance of foreign substances from
the body with a minimal risk of accumulation of the
oxygenated intermediates that might lead to cancer,
mutation, or toxicity (16,31).
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FIGURE 10. Representative catalytic activities encoded by the six genes of the [Ah] battery (16). Substrates include benzo(a)pyrene for
CYPIAl, acetanilide and 2-acetylaminofluorene for CYP1A2, the two-electron reduction of numerous quinones for Nmo-1, naphthaldehyde
for Aldh-1, p-nitrophenol and 4-methylumbelliferone for Ugt-i, and 1-chloro-2,4-dinitrobenzene for Gt-1.
It is important to emphasize that Phase II enzymes
can operate independently of Phase I enzymes, in ad-
dition to being tightly coupled in some instances as de-
scribed above. For example, the Phase II glucuroni-
dation reaction shown in Figure 11 requires the Phase
I P-450 reaction, whereas the Phase II quinone reduc-
tion shown in Figure 11 can occur with either the start-
ing chemical or the Phase I metabolite as the substrate
for Nmo-1. Just as the Phase I and Phase II enzymes
are able to act on substrates independently, so we shall
demonstrate below that the [Ah] battery Phase I genes
can be regulated independently of the [Ah] battery
Phase II genes.
CYPlAl and CYP1A2 Genes
TheP-450 superfamily currentlycomprises morethan
19 gene families, 10 of which exist in all mammals. A
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FIGURE 11. Examples of Phase I and Phase II metabolism with a
hypothetical starting substrate (left).
nomenclature system based on evolution has been pro-
posed (32). For naming a gene, the root symbol CYP
(Cyp for mouse) denoting cytochrome P-450, is rec-
ommended; this is followed by a number designating
the P-450 gene family, a letterindicatingthe subfamily,
and an Arabic numeral representing the individual
gene. Current estimates of the total number of func-
tional P-450 genes in any one mammalian species range
between at least 60 and perhaps more than 200. All of
these genes are believed to have arisen by divergent
evolution, i.e., from a common ancestral gene that ex-
isted probably more than 2.5 billion years ago. A major
driving force for the large number of gene duplications
is believed to be animal-plant warfare (16,33).
As mentioned above, CYPlAl and CYP1A2 are the
two Phase I genes defined as members ofthe [Ah] bat-
tery. CYPiAl and CYP1A2 are the only two members
of the P450I gene family (32). Little is known about
mammalian CYP1A2 gene regulation. Possibilities of
control elements inside the gene and more than 2 kb
upstream from the mRNA cap site have been suggested
(34,35). Further discussion ofCYP1A2 gene regulation
is beyond the scope ofthis review.
More is known about the regulation ofCYPlAl gene
expression than that of any other P-450 gene. A wealth
ofinformation has been gained through the use ofplas-
mids containing mouse or rat CYPiAl upstream se-
quences and the chloramphenicol acetyltransferase re-
porter gene, sometimes with anheterologous promoter.
These constructs have beentransfected into mouse hep-
atoma Hepa-1 wild-type cell cultures, as well as
CYPlAl metabolism-deficient (P1), receptorless (r-),
andchromatinbinding-defective (cb-) mutantlines (16).
As illustrated in Figure 12, about 1 kb upstream from
the mRNA cap site lies an aromatic hydrocarbon-re-
sponsive domain (AhRD), comprising three aromatic
hydrocarbon-responsive elements (AhREs) spaced ap-
proximately 80 bp apart (36,37). Gel mobility shift and
methylation interference assays have demonstrated the
FIGURE 12. Diagram of the regulatory regions upstream from the
mammalian CYPiAl gene. The precise location of the element
participating in the negative autoregulatory loop remains to be
determined. Although not indicated, there is a TATA box pro-
moter less than 30 bp upstream from the mRNA cap site.
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FIGURE 13. Suggested model in which the same repressor is com-
mon to both the Phase I CYPiAl gene and the Phase II Nmo-1
gene. Modified and redrawn from Robertson et al. (39). It is now
clear that this hypothesis is too simplistic.
interaction ofa functional Ah receptor with the AhRD.
Another element about 200 bp upstream from the cap
site is absolutely essential for all constitutive and in-
ducibleCYPlAl geneexpression; thisproximalelement
is necessarybutnotsufficientforinduciblegene expres-
sion, but interaction of the proteins that bind to the
proximalelement withthosebindingtothedistalAhRD
appears to be required for full CYPiAl induction by
TCDD (38). Another element in the upstream CYPlAl
regulatory sequences involves a negative autoregula-
tory loop; in the absence of a functional gene product
in PT1 cells, there is an apparent derepression of con-
stitutive CYPlAl transcription (16).
Intriguingly, theNmo-1 gene is alsotranscriptionally
activated in untreated P 1 cells (39), suggestingamech-
anism ofcommon repression of[Ah] battery genes that
requires a functional CYPlAl gene product (the en-
zyme) (Fig. 13). Transfection and expression of an ex-
ogenous CYPiAl cDNA in P1 cells represses the en-
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dogenous CYPlAl mRNA to constitutive levels seen
in wild-type cells, suggesting further this intimate re-
lationship betweenCYPlAl andNmo-1 generegulation
(A. Puga, B. Raychaudhuri, and D. W. Nebert, manu-
script submitted).
Radiation Deletion Mouse Lines
Inbred mouse lines with overlapping radiation-in-
duced chromosomal deletions involving the albino locus
(c) on chromosome 7 have been examined, and indirect
evidence has been found for regulatory genes located
within the missing region of deletion homozygote mice
(40-46). These regulatory loci appear to encode trans-
acting factors that modulate the basal and inducible
expression of genes that are located on other chromo-
somes. In most cases these genes are downregulated
about 2- to 4-fold in the deletion homozygote (C14Cos/
c14COS), while the wild-type (cch/cch) and the deletion
heterozygote (cch/C14cos) areunaffected (42-46). Forex-
ample, the expression ofglucose-6-phosphatase (42), ty-
rosineaminotransferase (Tat)andphosphoenolpyruvate
carboxykinase (Pepck) -induction by glucocorticoids
(44,45), and metallothionein (46) is2-to4-fold decreased
in the 14CoS/14CoS mouse, compared with the ch/ch
and the ch/14CoS mouse, suggesting a gene on chro-
mosome 7 that might encode one or more trans-acting
positive regulatory factor(s). However, the expression
of UDP-glucuronosyltransferase activity with p-nitro-
phenol as substrate (40) and glutathione transferase ac-
tivity with 1-chloro-2,4-dinitrobenzene as substrate (41)
was reported to be about 2-fold higher in untreated
14CoS/14CoS than in untreated ch/ch or ch/14CoS new-
borns. We believe that these two enzyme activities cor-
respond to the Ugt-1 and Gt-1 genes, respectively (Fig.
10). The data thus suggest that a gene on chromosome
7 encodes atrans-acting negative regulatoryfactorthat
plays an important role in Ah battery regulation.
In the untreated 14CoS/14CoS mouse, we had ex-
pected to find the [Ah] battery Phase I and Phase II
genes to be regulated in coordination, as appears to be
the case in the untreated PT1 cell lines (39). However,
Nmo-1 gene activation, but not CYPiAl or CYP1A2
geneactivation, wasfoundinuntreatednewborn 14CoS/
14CoSmice (47). The constitutive expression ofallthree
genes was nilin untreated newborn ch/ch and ch/14CoS
mice. Nmo-1 transcription was increased more than 12-
fold, whereas mRNA levels were increased more than
100-fold in newborn 14CoS/14CoS mouse liver. These
results indicate that the regulation ofbasal expression
ofthe Nmo-1 gene is distinct from that ofthe CYPiAl
and CYP1A2 genes. On the other hand, all three genes
are inducible by TCDD in these mice (47), demonstrat-
ing that TCDD inducibility is independent ofthe chro-
mosome 7-mediated mechanism ofNmo-1 gene activa-
tion in untreated 14CoS/14CoS newborns. Recent work
with the Aldh-i- gene has shown that it behaves iden-
tically to the Nmo-1 gene in P 1 cells and in the 14CoS/
cch
c3H
cB14i
C14CoS
tp c Mod-2
i
mRNA LEVELS
sh-1 Nmo-l Cyplal Cypla2
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1 cM
FIGURE 14. Diagram of a small region around the albino (c) locus
on chromosome 7, the approximate sizes of the deletions in the
three mouse lines studied in this report [modified and redrawn
from Gluecksohn-Waelsch (42) and Russell et al. (43)] and the
levels ofNmo-1, CYPlAl and CYP1A2 mRNA found in the un-
treated wild-type homozygote (cch/cch) and the three deletion
homozygotes examined. (tp) Gene for taupe coat color; Mod-2 lo-
cus, mitochondrial malic enzyme; sh-1, gene for shaker-1. (±)
Below level ofdetection; (+ + ++) > 100-fold increases.
14CoS mice (D. D. Petersen and D. W. Nebert, manu-
script in preparation).
To define more precisely the chromosomal location of
the putative trans-acting gene, we screened three mu-
tantmouselineshavingdeletionsthatincludetheclocus
(Fig. 14). Nmo-1 mRNA was found to be markedly el-
evated in the untreated 3H/3H and the 14CoS/14CoS,
but not the Bi4/Bi4 deletion homozygote. We therefore
postulate that a novel gene encoding a putative trans-
acting regulatory factor that negatively controls the
Nmo-1 gene is located on chromosome 7 within an ap-
proximately 1.1-cM region.
It has been estimated that, on the average, about 30
genes would be present in aregion of1.0 cM ofgenomic
DNA (48). Therefore, we would expect that the 14CoS/
14CoS deletion might comprise less than three dozen
genes, with a range of perhaps one to 100 genes.
Regulatoryproteinscanhaveapositiveeffectontran-
scription under one set ofcircumstances and a negative
effect under another (49). It is therefore conceivable,
although quite unlikely, that the elevated expression of
Nmo-1 mRNA (47), Aldh-1 mRNA, and Ugt-1 and Gt-
1 enzyme activities (40,41), as well as the decreased
expression of the four genes described above (42-46),
might represent the action of the same gene that is
missing in the 14CoS/14CoS deleted chromosomal re-
gion. We have indirect evidence suggesting that this is
not, however, the case. Several SV40-transformed ch/
ch, ch/14CoS, and 14CoS/14CoS mouse liver lines have
been established and characterized; while the Nmo-1
response in the 14CoS/14CoS cell lines is identical to
that seenin 14CoS/14CoS newborn mouse liver, the Tat
and Pepek response to dexamethasone is not (J. Chou,
D. D. Petersen, and D. W. Nebert, unpublished). We
therefore believe these data support the notion that the
chromosome 7 gene encoding the trans-acting negative
regulatory factor is different from that encoding the
trans-acting positive regulatory factor.
Figure 15 illustrates our current hypothesis on the
[Ah] regulatory pathways inthe wild-type ch/chmouse,
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FIGURE 15. Proposed scheme for several interactive levels of regulation between the CYPlAl gene and the Nmo-1 gene in (A) the wild-
type ch/ch mouse and (B) the 14CoS/14CoS deletion homozygote mouse. The encircled minus signs denote putative negative control elements
whose precise locations are not yet known. The putative endogenous substrate, metabolite, proRepressor, and repressormolecules (denoted
by question marks) are not known. The CYPlAl, Nmo-1, and Nmo-ln genes have been mapped to mouse chromosomes 9, 8, and 7,
respectively (16,47). Chromosomal location ofthe gene encoding the putative negative effector of CYPlAl transcription is not known.
as compared with that in the 14CoS/14CoS deletion
homozygote. It should be emphasized that we began
our search for a putative repressor gene acting on the
expression ofall [Ah] battery genes (Fig. 13). Instead,
we have localized a putative repressor gene on mouse
chromosome 7 that acts on the expression of [Ah] bat-
teryPhase II genes, butnot[Ah] batteryPhase Igenes.
Because studies of this chromosome 7 gene affecting
Aldh-1, Ugt-1, and Gt-1 gene expression are still pre-
liminary, we propose the name Nmo-ln for the gene
encoding a negative effector ofNmo-1 gene transcrip-
tion. The presence oftwocopies orone copyoftheNmo-
in gene on mouse chromosome 7 (Fig. 16) is sufficient
cch /cch
4,
GENE
PRODUCT
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OI
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OF [Ah] BATTERY
PHASE I GENES
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PRODUCT
DEREPRESSION
OF [Ah] BATTERY
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torepressthe [Ah] batteryPhase IIgenes. Onthe other
hand, absence ofboth copies ofthe Nmo-ln gene leads
to the putative derepression ofthe [Ah] battery Phase
II genes (Fig. 16), in a mechanism that is independent
ofregulation of the [Ah] battery Phase I genes.
Rat Liver Preneoplastic Nodules
Rat liver preneoplastic nodules have been studied as
a model system for tumor progression (50). The rats
are fed one of several carcinogens, such as 2-acetylam-
inofluorene, followed by injury to the liver, such as car-
bon tetrachloride (cell death), or partial hepatectomy
(decrease in organ cell number). These stimuli lead to
the proliferation, or clonal expansion, of cells initially
changed by a mutation. Only a small percentage ofpre-
neoplastic nodules actually proceed to frank malig-
nancy. Interestingly, the CYPlAl and CYP1A2 en-
zymes are undetectable, while theNmo-1, Aldh-1, Ugt-
1, and Gt-1 enzyme activities in the preneoplastic nod-
ules are elevated (16,27,29,50,51). It appears likely that
these previous results with rat liver preneoplastic nod-
ules are related to ourrecent observations that the mu-
rine [Ah] battery Phase II gene regulation is indepen-
dent of the [Ah] battery Phase I gene regulation.
FIGURE 16. Diagram of the chromosome 7 regions in the three
mouse genotypes. (X) Location ofthe putative Nmo-ln gene. The
open area defined by parentheses denotes the radiation-induced
deletion. With both copies of the Nmo-ln gene absent, there is
the release from negative control of the [Ah] battery Phase II
genes, whichisindependentofregulationofthe[Ah]batteryPhase
I genes.
Michael Reaction Acceptors
Michael acceptors are potent electrophilic compounds
with an electron-withdrawing group one carbon atom
removed from an olefinic double bond (Fig. 17). In an
intriguing report, Talalay and co-workers compared a
series of Michael acceptors and found that the Nmo-1
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FIGURE 17. Mechanism by which an electrophilic Michael reaction
acceptorinteracts with anintracellularnucleophilic macromolecule
[Nucl:'-']. (Z) An electron-withdrawing moiety.
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FIGURE 18. Illustration ofthe scheme in which [Ah] battery Phase
I metabolism is suggested to be a prerequisite for the induction
of [Ah] battery Phase II genes (52): It is now clear that this
hypothesis is too simplistic.
inducing properties of several Michael reaction accep-
tors generally parallel the potency ofthe electron-with-
drawing group (52). It was therefore postulated that
Phase I metabolism is essential in order to produce me-
tabolites that willinduce Phase II genes (Fig. 18). How-
ever, the P1 cells (39) have no CYPlAl or CYP1A2
gene expression, and the untreated 14CoS/14CoS new-
born mice (47) have no detectable CYPlAl or CYP1A2
expression, yet Nmo-1 and Aldh-1 gene expression is
markedly increased in both instances. Hence, in view
of these results, we believe that Phase I metabolism
per se is not essential for [Ah] battery Phase II gene
induction.
DNA Damage and Nmo-1 Induction
We have found that chemicals as diverse as mena-
dione, butylated hydroxytoluene, and methylmethane-
sulfonate (MMS)especially atnear-toxicconcentrations,
activate Nmo-1 gene expression in Hepa-1 wild-type
cells (D. D. Petersen, A. J. Fornace, Jr., K. Dixon, and
D. W. Nebert, manuscript in preparation). One prop-
erty these chemicals have in common is that they are
all capable of causing DNA damage. In support of this
hypothesis, the Nmo-1 enzyme has been found to acti-
vate 5-(aziridin-1-yl)-2,4-dinitrobenzamide to a new cy-
totoxic DNA crosslinking agent, 5-(aziridin-1-yl)-4-hy-
droxylamino-2-nitrobenzamide, which induces Nmo-1
mRNA in Walker rat carcinoma cells (53; John J. Rob-
erts, personal communication). Moreover, 5-azacytidine
and dietary methyl-group deficiency in mice induce
Nmo-1 mRNA and certain glutathione transferase ac-
tivities (54). In fact, the introduction of UV-damaged
DNA alone into Hepa-1 wild-type cells in culture also
activatesNmo-1 expression (D. D. Petersen, A. J. For-
nace, Jr., K. Dixon, and D. W. Nebert, manuscript in
preparation). These data strongly suggest that the sig-
nal for Nmo-1 gene activation can be mediated by way
of DNA damage.
DNA Damage-Inducible Genes
If DNA damage induces the [Ah] battery Phase II
genes as one subset, how many other classes of DNA
damage-inducible genes might exist in the mammalian
cell? To approach this question, hybridization subtrac-
tion was used to enrich UV-induced cDNAs of tran-
scripts in Chinese hamster cells (55). Of 49 different
cDNA clones characterized, most encode nonabundant
transcripts that become rapidly induced 2- to 10-fold
after UV irradiation. Two of the cDNA clones se-
quenced were metallothionein I and II, respectively,
and another had significant homology with a rat DNA
helix-destabilizing protein. Of 23 cDNA clones chosen
for further study, none of the nucleotide sequences
matches anything in the latest GenBank data base.
These 23 genes, believed to represent single-copy
genes, were categorized according to their response to
various DNA-damaging agents (Table 1). Class I tran-
scripts are induced by UV irradiation but not by the
alkylatingagentMMS. Class IIatranscripts areinduced
by both UV and MMS, whereas Class IIb transcripts
are induced 2- to 6-fold by UV but 10- to > 25-fold by
MMS and other alkylating agents. Interestingly, we
found that the three Class Ilb transcripts are markedly
elevatedintheuntreated 14CoS/14CoSnewbornmouse,
but not in the untreated ch/ch or ch/14CoS newborn
mouse (56).
Growth Arrest-inducible Genes
DNA damage has distinct effects on the normal cell
cycle. During typical cell growth, the following phases
Table 1. Induction of DNA damage-inducible transcripts by
various agents.a
Induction
Nucleotide
excision Base excision Heat
eDNA probe UV AAAF MMS H202 shock
Class I (10 genes) + + 0 0 0
Class IIa
(10 genes) + + + + 0
Class IIb
(3 genes) + + + + + + 0
HSP70 0 0 0 0 + +
,-Actin 0 0 0 0 0
a(+) Denotes 2- to 10-fold, (+ +) denotes 10- to > 25-fold. Excep-
tions: most of the UV induction was < 6-fold, clone A15 (Class Ila)
was heat shock-inducible (55). UV, ultraviolet irradiation; AAAF, N-
acetoxy-2-acetylaminofluorene; MMS, methylmethanesulfonate;
H202, hydrogenperoxide. Nucleotide excision and base excision refer
to the types of DNA repair induced by UV (or AAAF) and MMS (or
H202), respectively.
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in the cell cycle have been described (Fig. 19): G1, S
(when DNA synthesis occurs), G2, and M (when mitosis
occurs). The Go phase denotes nongrowing cells that
have left the cell cycle. DNA damage is known to delay
progression through the cell cycle and entry into mi-
tosis. In many cases, such delays probably represent
active, cell-programmed processes and not simply the
deleterious effects ofDNA damage. For example, in E.
coli a role in the inhibition of cell growth is played by
the sulA gene, a member of the SOS regulon that is
DNA damage-inducible (57). In yeast cells, the Rad9
gene product is responsible for the arrest ofcells in G2
produced by X-irradiation, and this G2 arrest is absent
in the radiosensitive rad9 mutant (58). There appear to
be numerous check-and-balance functions that normally
operate during the cell cycle, and these functions can
be induced by DNA damage or other types ofstress to
the cell. For example, in human, rodent, Drosophila,
slime mold, and fungal cells, the transient inhibition of
DNA synthesis-seen after DNA damage-is de-
creased orabsentin certain DNAdamage-sensitive mu-
tants (58,59).
We reasoned that a subset ofDNA damage-inducible
genes might be growth arrest-inducible. We therefore
examinedmRNAfromgrowth-arrestedcellsbyprobing
witheachofthe23geneslistedinTable 1. Interestingly,
five DNA damage-inducible transcripts, including the
three IIb genes, are increased by several growth ces-
sation signals: serumreduction, medium depletion, con-
tact inhibition, and a 24-hr exposure to hydroxyurea.
These five genes have been designated the gadd genes,
for growth arrest and DNA damage inducible (56).
In conclusion, certain stimuli elicit the activation of
the [Ah] battery Phase I genes, other stimuli the [Ah]
battery Phase II genes, and still other stimuli thegadd
genes(Table2). These dataareconsistentwiththepres-
ent-day concept ofmodularity in promoters and enhan-
cers (60). The promoters and enhancers that control
transcription comprise multiple genetic elements, or
modules. The cellular transcriptional machinery is able
to gather and integrate the regulatory infornation con-
veyed by each module, and this information can be de-
velopmental-, sex- or tissue-specific. These integrated
signals allow different sets (or batteries) of genes to
evolve distinct, often complex, patterns of transcrip-
tional regulation. It will be interesting to compare the
regulatory elements ofthe [Ah] battery Phase I genes,
the [Ah] battery Phase II genes, and the gadd genes.
FIGURE 19. The normal cell growth cycle.
Table 2. Summary of the responses of three sets of genes to five
experimental conditions.'
14CoS/14CoS Growth
TCDD P,-mutant mouse MMS arrest
[Ah] battery + + + + 0 0 0
Phase I genes
[Ah] battery + + + + + + + + 0
Phase II genes
gadd genes 0 0 + + + + + +
a(+ +) Denotes significant (2 2-fold) gene activation; (0) no sig-
nificant gene activation.
I Genes- HGenes
\ I + 11+
FOODS F-OH
DRUGS O=F=O
Electrophilic
Michael reaction.
acceptors
F-O-Conjugate
F(OH)2
FIGURE 20. Hypothetical scheme bywhich [Ah] batteryPhase I and
Phase II genes and gadd genes respond to oxidative stress. (F)
Chemicals in foodstuff.
Conclusions
In summary, a variety of inducers that bind to the
Ah receptor are positive activators of [Ah] battery
Phase I and Phase II genes (Fig. 20). Numerous oxy-
genated metabolites, including phytoalexins, cause
DNA damage irrespective of whether or not Phase I
metabolism occurs. Both DNA damage and growth ar-
rest are known to produce a transient slowing in rep-
lication. It is somewhere herein that the Nmo-ln gene
senses an unknown signal that the cell is in distress.
TheNmo-ln gene thus responds byreleasingits neg-
ative control on the [Ah] battery Phase II genes and
perhaps the gadd genes, thereby allowing all of these
genes to become expressed. Hence, we conclude that
theregionofmousechromosome 7missinginthe 14CoS/
14CoS mouse contains a master switch gene that re-
sponds to environmental adversity, such as oxidative
stress. This response is independent of Phase I
(CYPlAl and CYP1A2) gene expression. Whether this
region onchromosome 7represents asinglegene, Nmo-
ln, controlling both the [Ah] battery Phase II genes
and the gadd genes, or whether there are two or more
genes controlling the [Ah] battery Phase II genes and
thegadd genes will only be clarified after furtherwork.
In eukaryotic cells, as in prokaryotes, there is likely
to be a finite number of global mechanisms (batteries
of genes activated in coordination) that respond to a
nearly infinite number of adverse environmental stim-
uli. For example, the global responses of bacteria to
DNA damage are known to include the H202-inducible
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pathways (1), theadaptiveresponse toalkylatingagents
(2), the heat shock system, mismatch repair (3), and the
SOS regulatory system (4). The OxyR-regulated H202-
inducible system (1) is clearly different from the [Ah]
gene battery. The adaptive response appears to be lim-
ited to the induced synthesis of certain enzymes that
repair alkylating lesions in DNA (2). Interestingly, the
hypothesis involving the [Ah] gene battery illustrated
in Figure 20 is quite similartothe recAllexA-regulation
ofthe prokaryotic SOS response shown in Figure 21.
It is well known that during the SOS response an
identical set of pleiotropic effects is seen following a
variety ofstresses thatdamage DNA orinterrupt DNA
replication in E. coli. The responses to these stresses
include anincreased capacity for DNArepair, enhanced
mutagenicity, growth arrest, filamentation ofcells, ces-
sation of respiration, DNA degradation, increases in
stable DNA replication, and induction ofsome resident
prophages (60). We are currently attempting to corre-
late these prokaryotic processes with their eukaryotic
equivalents and to understand the role played by acti-
vation ofthe [Ah] battery Phase II and gadd genes.
The [Ah] gene battery appears to be involved in both
apoptosis and the cellular responlse to oxidative stress.
What do these two processes have in common? It re-
mains to be determined whether TCDD-induced apop-
tosis (18) is caused by the induction of Phase I genes,
the induction of Phase II genes, or another process be-
yond Phase I and Phase II gene activation. Apoptosis
involves the programmed death of some cells, so that
others might survive. Such a process normally involves
endogenous signals and is seen in embryonic develop-
ment, normal tissue turnover, and hormone-dependent
atrophy. We suggest that a process similar or identical
to apoptosis, involving exogenous signals (e.g., phyto-
alexins), might occur during tumor promotion (Fig. 6).
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FIGURE 21. Diagram of the overall SOS response in prokaryotes.
Modified and redrawn from Ossanna et al. (4).
In the face ofchemical adversity, the primary drive for
the eukaryotic or prokaryotic cell is to survive. In eu-
karyotic cells, it is clear that the [Ah] gene battery
participates in this function.
This paper is dedicated to the memory ofErnst W. Caspari, 1910-
1988. We thank our colleagues, especially Kathleen Dixon, for valu-
able discussions and the careful reading of this manuscript.
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